These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19540656)

  • 1. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
    Hohmann J; Newerla C; Müller A; Reinicke C; Skrok J; Frericks BB; Albrecht T
    J Magn Reson Imaging; 2012 Dec; 36(6):1389-94. PubMed ID: 22893441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
    Zhou JH; Li AH; Cao LH; Jiang HH; Liu LZ; Pei XQ; Han F
    Br J Radiol; 2008 Feb; 81(962):113-9. PubMed ID: 18070827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
    Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
    J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.
    Guadagni S; Pizzutilli A; Mancini E; Varrone A; Palumbo G; Amicucci G; Perri S; Deraco M; Fiorentini G
    Eur J Surg Oncol; 2000 Jun; 26(4):381-6. PubMed ID: 10873360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls].
    Haendl T; Strobel D; Neureiter D; Esser K; Frieser M; Hahn EG; Bernatik T
    Ultraschall Med; 2010 Dec; 31(6):582-8. PubMed ID: 20183780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of quantitative assessment of altered hepatic hemodynamics with dynamic contrast-enhanced ultrasound.
    Gauthier TP; Muhammad A; Wasan HS; Abel PD; Leen EL
    J Ultrasound Med; 2012 Sep; 31(9):1413-20. PubMed ID: 22922621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative diagnosis of early-stage liver cirrhosis with contrast-enhanced ultrasound--a clinical study.
    Shi Y; Wang XH; Xia GC; Lei CG
    Adv Clin Exp Med; 2012; 21(3):385-90. PubMed ID: 23214202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers].
    Kissel A; Rixe O; Methlin A; Nabet M; Tranquart F; Rubini B; Jafaar S; Gaucher H
    J Radiol; 2001 Nov; 82(11):1621-5. PubMed ID: 11894547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
    Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
    Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Hepatic Transit Time and Shear Wave Velocity in Assessing Portal Pressure in Patients with Cirrhotic Portal Hypertension.
    Lin Y; Liu Y; Jiang B; Li W; Li H; Wang H
    Ultrasound Med Biol; 2021 Feb; 47(2):272-278. PubMed ID: 33153804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler perfusion index and contrast-enhanced ultrasound in patients with colorectal cancer liver metastases.
    Ruan L; Wang S; Zhang J; Ai H; Zhao Q; Yang J; Wei W
    Hepatogastroenterology; 2014; 61(129):37-41. PubMed ID: 24895790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles.
    Shunichi S; Hiroko I; Fuminori M; Waki H
    Ultrasound Med Biol; 2009 Nov; 35(11):1819-27. PubMed ID: 19713032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients.
    Lin YQ; Jiang B; Li HQ; Jin CX; Wang H
    J Ultrasound Med; 2019 Sep; 38(9):2305-2314. PubMed ID: 30609088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of ultrasonography in the diagnosis and treatment tracing of hepatocellular carcinoma-associated arteriovenous fistulas.
    Li YY; Duan YY; Yan GZ; Lv FQ; Cao W; Cao TS; Yuan LJ
    Liver Int; 2007 Aug; 27(6):869-75. PubMed ID: 17617131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.
    Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX
    World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic vein transit time of SonoVue: a comparative study with Levovist.
    Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ
    Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.